马上注册，结交更多好友，享用更多功能，让你轻松玩转社区。
您需要 登录 才可以下载或查看，没有账号？立即注册
x
本帖最后由 tshwangq 于 2012-3-16 00:19 编辑
内容我翻译不好，直接贴过来吧
转自:mct.aacrjournals.org/content/11/2/452.short
Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1–Mediated Inhibition of STAT3
Wei-Tien Tai3,4, Ann-Lii Cheng2,3, Chung-Wai Shiau5, Chun-Yu Liu5,6, Ching-Huai Ko7, Mai-Wei Lin7, Pei-Jer Chen1, and Kuen-Feng Chen1,3
+ Author Affiliations
Authors' Affiliations: Departments of 1Medical Research and 2Oncology, 3National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital; 4Graduate Institute of Molecular Medicine, National Taiwan University College of Medicine; 5Institute of Biopharmaceutical Sciences, National Yang-Ming University; 6Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei; and 7Cell Engineering Lab, Biomedical Technology and Device Research Labs, Industrial Technology Research Institute, Hsinchu, Taiwan
Corresponding Author:
Kuen-Feng Chen, Department of Medical Research, National Taiwan University Hospital, No 7, Chung-Shan S Rd, Taipei 100, Taiwan. Phone: 886-2-23123456, ext. 63548; Fax: 886-2-23225329; E-mail: kfchen1970@ntu.edu.tw
Abstract
The multiple kinase inhibitor dovitinib is currently under clinical investigation for hepatocellular carcinoma (HCC). Here, we investigated the mechanistic basis for the effects of dovitinib in HCCs. Dovitinib showed significant antitumor activity in HCC cell lines PLC5, Hep3B, Sk-Hep1, and Huh-7. Dovitinib downregulated phospho-STAT3 (p-STAT3) at tyrosine 705 and subsequently reduced the levels of expression of STAT3-related proteins Mcl-1, survivin, and cyclin D1 in a time-dependent manner. Ectopic expression of STAT3 abolished the apoptotic effect of dovitinib, indicating that STAT3 is indispensable in mediating the effect of dovitinib in HCC. SHP-1 inhibitor reversed downregulation of p-STAT3 and apoptosis induced by dovitinib, and silencing of SHP-1 by RNA interference abolished the effects of dovitinib on p-STAT3, indicating that SHP-1, a protein tyrosine phosphatase, mediates the effects of dovitinib. Notably, dovitinib increased SHP-1 activity in HCC cells. Incubation of dovitinib with pure SHP-1 protein enhanced its phosphatase activity, indicating that dovitinib upregulates the activity of SHP-1 via direct interactions. In addition, dovitinib induced apoptosis in two sorafenib-resistant cell lines through inhibition of STAT3, and sorafenib-resistant cells showed significant activation of STAT3, suggesting that targeting STAT3 may be a useful approach to overcome drug resistance in HCC. Finally, in vivo, dovitinib significantly suppressed growth of both Huh-7 and PLC5 xenograft tumors and downregulated p-STAT3 by increasing SHP-1 activity. In conclusion, dovitinib induces significant apoptosis in HCC cells and sorafenib-resistant cells via SHP-1–mediated inhibition of STAT3. Mol Cancer Ther; 11(2); 452–63. ©2011 AACR.
Received June 14, 2011.
Revision received November 27, 2011.
Accepted December 7, 2011. |
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
千斤顶
显身卡
